India Glycols Announces Q1FY27 Earnings Conference Call on Aug 14
India Glycols Limited will host its Q1FY27 Earnings Conference Call on August 14, 2026, at 16:00 Hrs IST. Key management, including the CEO and CFO, will participate. Dial-in details and contact information for inquiries have been provided.
This is a routine disclosure about an upcoming conference call to discuss quarterly earnings. It does not contain any new material information about the company's performance or future outlook that would significantly impact its stock price or investor decisions.
The announcement is a routine intimation of a conference call for Q1FY27 earnings, which is a standard practice for listed companies. It does not contain any specific financial results or forward-looking guidance that would indicate a positive or negative sentiment.
India Glycols Limited has announced its Q1FY27 Earnings Conference Call, scheduled to be held on Friday, August 14, 2026, at 16:00 Hrs IST. The call will feature key management personnel including Mr. Rupark Sarswat (Chief Executive Officer), Mr. Manoj Kumar Rai (Executive Director & COO, IGL Spirits Limited), Mr. Akshay Bansal (Executive Director, Ennature Bio Pharma Limited), Mr. Anand Singhal (Chief Financial Officer), Mr. S. K. Shukla (Head, Liquor Business), and Mr. Ankur Jain (Head, Legal and Company Secretary).
Participants can join the call using the provided universal dial-in numbers for India (+91 22 6280 1527 or +91 22 7115 8322) and international toll-free numbers for USA, UK, Singapore, and Hong Kong. The company has also provided a link for Express Join via DiamondPassTM. For any inquiries regarding the conference call, interested parties can contact InCred Equities Team at the provided contact details or email silketha.quinny@incredresearch.com or +91 98923 80170.
This disclosure is made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The information is also hosted on the company's website at www.indiaglycols.com.
What to do with a filing like this
India Glycols Limited filed this with the NSE as a statutory disclosure, categorised under concall scheduled. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by India Glycols Limited. Read the original for the full detail.